Ozempic is more often covered when prescribed for type 2 diabetes, but less commonly for weight loss
A key differentiator of CT-388 lies in its design to produce potent activity on both the GLP-1 and GIP receptors, along with minimal-to-no -arrestin recruitment on either receptor
This makes it an excellent option for post-operative care, helping to shorten recovery time and manage discomfort
Patients say having options is 'fantastic' While authorities and pharmaceutical companies ponder how to manage the issue of compounded diabetes drugs circulating in Australia, some consumers are just relieved they have the option to take them
The chemical is currently being studied for its effects on diabetes and heart disease but has been flying off the shelves as a weight loss supplement ever since the GLP-1 craze swept the country
Vani GT, Mukesh N, Siva Prasad B et al (2010) Role of glutathione S-transferase Mu-1 (GSTM1) polymorphism in oligospermic infertile males